7th Annual Advances in Gastroenterology and Hepatology Conference

7th Annual Advances in Gastroenterology and Hepatology Conference is organized by UC San Diego School of Medicine (UCSD SOM) and will be held on Feb 02, 2019 at University Of California, San Diego, La Jolla, California, United States of America.

Target Audience:
This initiative is designed for gastroenterologists, primary care physicians, internal medicine physicians and other healthcare professionals who care for patients with GI issues.

Accreditation:
The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA: The University of California San Diego School of Medicine designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 7.75 hours of Category 1 credit for completing this program.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit™ (report up to 7.75 hours of credit and list "CME Category 1" as the provider number).

Course Description:
This interactive one-day activity will present cutting-edge new opportunities for improving assessment and management of patients with gastrointestinal conditions, and place recent advances in context of current assessment and management paradigms.

Specific topics that will be covered include: optimizing polyp detection and removal; colorectal polyp surveillance; Crohn's disease; pouchitits, autoimmune hepatitis; hepatocellular cancer screening; optimizing outcomes of endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS); injury prevention for the endoscopists; autoimmune hepatobilliary disease; achalasia and achalasia variants; GI bleeding; cannabis therapy for gastrointestinal disease.

The format includes keynote presentations by internationally known guest speakers, short, evidence-based updates by UC San Diego faculty, and interactive presentations and panel discussions of challenging cases.

Educational Objectives:
At the completion of this symposium, participants should be able to:
• Implement current strategies for colorectal screening
• Review updates to national colon polyp surveillance guidelines
• Apply optimal approaches to identification and management of Crohn’s disease and pouchitis
• Identify autoimmune hepatitis
• Recall current evidence to support screening for hepatocellular carcinoma
• Apply novel approaches to optimizing outcomes of ERCP and EUS
• Examine the best approaches to diagnosing and managing hepatic encephalopathy
• Apply strategies for avoiding endoscopist injury
• Describe advances in diagnosis of autoimmune hepatobilliary disease
• Identify approaches to identify achalasia and achalasia variants
• Implement an evidence-based approach to the diagnosis and management of obscure GI Bleeding
Assess the evidence for use of cannabis therapy to treat gastrointestinal disease.